|
1) Unger RH. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes. 1995; 44: 863-70
|
|
|
|
2) Leonard AE, Pereira SL, Sprecher H, et al. Elongation of long-chain fatty acids. Prog Lipid Res. 2004; 43: 36-54
|
|
|
|
|
|
3) Guillou H, Zadravec D, Martin PG, et al. The key roles of elongases and desaturases in mammalian fatty acid metabolism: Insights from transgenic mice. Prog Lipid Res. 2010; 49: 186-99
|
|
|
|
|
|
4) Tvrdik P, Asadi A, Kozak LP, et al. Cig30, a mouse member of a novel membrane protein gene family, is involved in the recruitment of brown adipose tissue. J Biol Chem. 1997; 272: 31738-46
|
|
|
|
|
|
5) Westerberg R, Tvrdik P, Undén A, et al. Role for ELOVL3 and fatty acid chain length in development of hair and skin function. J Biol Chem. 2004; 279: 5621-9
|
|
|
|
|
|
6) Westerberg R, Månsson JE, Golozoubova V, et al. ELOVL3 is an important component for early onset of lipid recruitment in brown adipose tissue. J Biol Chem. 2006; 281: 4958-68
|
|
|
|
|
|
7) Zadravec D, Brolinson A, Fisher RM, et al. Ablation of the very-long-chain fatty acid elongase ELOVL3 in mice leads to constrained lipid storage and resistance to diet-induced obesity. FASEB J. 2010; 24: 4366-77
|
|
|
|
|
|
8) Wang Y, Botolin D, Christian B, et al. Tissue-specific, nutritional, and developmental regulation of rat fatty acid elongases. J Lipid Res. 2005; 46: 706-15
|
|
|
|
|
|
9) Qin Y, Dalen KT, Gustafsson JA, et al. Regulation of hepatic fatty acid elongase 5 by LXRalpha-SREBP-1c. Biochim Biophys Acta. 2009; 1791: 140-7
|
|
|
|
|
|
10) Moon YA, Hammer RE, Horton JD. Deletion of ELOVL5 leads to fatty liver through activation of SREBP-1c in mice. J Lipid Res. 2008; 50: 412-23
|
|
|
|
|
|
11) Yahagi N, Shimano H, Hasty AH, et al. A crucial role of sterol regulatory element-binding protein-1 in the regulation of lipogenic gene expression by polyunsaturated fatty acids. J Biol Chem. 1999; 274: 35840-4
|
|
|
|
|
|
12) Wang Y, Torres-Gonzalez M, Tripathy S, et al. Elevated hepatic fatty acid elongase-5 activity affects multiple pathways controlling hepatic lipid and carbohydrate composition. J Lipid Res. 2008; 49: 1538-52
|
|
|
|
|
|
13) Pawar A, Jump DB. Unsaturated fatty acid regulation of peroxisome proliferator-activated receptor alpha activity in rat primary hepatocytes. J Biol Chem. 2003; 278: 35931-9
|
|
|
|
|
|
14) Tripathy S, Torres-Gonzalez M, Jump DB. Elevated hepatic fatty acid elongase-5 activity corrects dietary fat-induced hyperglycemia in obese BL/6J mice. J Lipid Res. 2010; 51: 2642-54
|
|
|
|
|
|
15) Matsuzaka T, Shimano H, Yahagi N, et al. Cloning and characterization of a mammalian fatty acyl-CoA elongase as a lipogenic enzyme regulated by SREBPs. J Lipid Res. 2002; 43: 911-20
|
|
|
|
|
|
16) Matsuzaka T, Shimano H, Yahagi N, et al. Crucial role of a long-chain fatty acid elongase, Elov16, in obesity-induced insulin resistance. Nat Med. 2007; 13: 1193-202
|
|
|
|
|
|
17) Matsuzaka T, Shimano H. Elovl6: a new player in fatty acid metabolism and insulin sensitivity. J Mol Med. 2009; 87: 379-84
|
|
|
|
|